Ryan M. Reddinger
Papers
1
Total Citations
176
H-Index
1
About
Ryan M. Reddinger is a pioneering bioengineer whose research centers on microphysiological systems and organ-on-a-chip technologies for drug development and toxicity screening. His most impactful contribution is the development and validation of the OrganoPlate® LiverTox™, a 3D microfluidic liver model that enables high-throughput hepatotoxicity screening. This work, published in 2021 and cited over 176 times, demonstrates the use of induced pluripotent stem cell (iPSC)-derived hepatocyte aggregates within an extracellular matrix, creating a physiologically relevant platform for compound testing. Reddinger’s innovation bridges the gap between traditional 2D cell culture and costly animal models, offering a scalable, automated solution for preclinical safety assessment. His achievements highlight a commitment to advancing alternative methods in toxicology, reducing reliance on animal testing while improving predictive accuracy. For students and researchers, Reddinger’s work exemplifies how integrating microfluidics, stem cell biology, and automation can transform drug discovery, making liver toxicity screening more efficient and human-relevant. His contributions are shaping the future of personalized medicine and safer pharmaceutical development.
Research Focus
Key Achievements
Top Papers
- 1